Investing

Macy's, Teva Join Wednesday's 52-Week Low Club

January 11, 2017: Here are four stocks trading with relatively heavy volume among 25 equities making new 52-week lows in Wednesday’s session. On the NYSE, advancers led decliners by more than 2 to 1 and on the Nasdaq advancers led decliners by about 7 to 6.

DryShips Inc. (NASDAQ: DRYS) dropped about 11.4% on Wednesday to post a new 52-week low of $2.34 against a 52-week high of $278.40 and a Tuesday close of $2.73. Volume of about 15 million was 80% higher than the daily average of around 8.5 million. Investors continue to run away from the company’s diversification in LPG shipping.

Merrimack Pharmaceuticals Inc. (NASDAQ: MACK) dropped about 4.7% on Wednesday to post a new 52-week low of $3.24 after closing at $3.40 on Tuesday. Volume was about 4 times the daily average of about 3.9 million shares. The stock’s 52-week high is $9.02 The company said Tuesday that it has sold some of its cancer drugs to Ipsen for $1 billion.

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA ) dropped about 4.7% Wednesday to post a new 52-week low of $33.56 after closing Tuesday at $35.20. The 52-week high is $65.20. Volume of around 13.4 million was about 35% above the daily average of around 10 million shares traded. At his press conference Wednesday, President-elect Trump drew a big target on high drug prices.

Macy’s Inc. (NYSE: M) dropped about 1.8% Wednesday, posting a new 52-week low of $29.75 after closing at $30.30 on Tuesday. The stock’s 52-week high is $45.50. The department store retailer had no specific news.

Find a Qualified Financial Advisor (Sponsor)

Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.